Department of Basic Sciences, School of Veterinary Medicine, Shiraz University, Shiraz, Iran.
Neuroscience Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Mol Biol Rep. 2021 Jul;48(7):5647-5660. doi: 10.1007/s11033-021-06520-9. Epub 2021 Jul 7.
Among different pathological mechanisms, neuronal loss and neurogenesis impairment in the hippocampus play important roles in cognitive decline in Alzheimer's disease (AD). AD is a progressive and complex neurodegenerative diseases, which is very debilitating. The purpose of this paper is to review recent research into neurogenesis and AD and discuss how pharmacological drugs and herbal active components have impacts on neurogenesis and consequently improve cognitive functions. To date, despite huge research, no effective treatment has been approved for AD. Therefore, an avenue for future research and drug discovery is stimulating adult hippocampal neurogenesis (AHN). Evidence suggests that neurogenesis is regulated by the pharmacological treatment that may be recommended as a part of prophylaxis and therapeutic options for AD. However, the underlying mechanisms of regulating neurogenesis in AD are not well understood. To this point, we highlight to achieve an efficient treatment in AD by manipulating neurogenesis, it's necessary to target all steps of neurogenesis.
在不同的病理机制中,海马神经元的丢失和神经发生损伤在阿尔茨海默病(AD)的认知能力下降中起着重要作用。AD 是一种进行性和复杂的神经退行性疾病,对人体危害极大。本文旨在综述神经发生与 AD 的最新研究进展,并探讨药理学药物和草药活性成分如何影响神经发生,进而改善认知功能。迄今为止,尽管进行了大量研究,但尚未批准任何有效的 AD 治疗方法。因此,未来的研究和药物发现方向是刺激海马体神经发生(AHN)。有证据表明,神经发生受药理学治疗的调节,这可能被推荐作为 AD 预防和治疗选择的一部分。然而,AD 中调节神经发生的潜在机制尚不清楚。在这一点上,我们强调通过操纵神经发生来实现 AD 的有效治疗,有必要针对神经发生的所有步骤。